These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32584440)

  • 1. White matter lesions and temporal atrophy are associated with cognitive and neuropsychiatric symptoms in patients with hypertension and Alzheimer's disease.
    García-Alberca JM; Mendoza S; Gris E; Royo JL; Cruz-Gamero JM; García-Casares N
    Int J Geriatr Psychiatry; 2020 Nov; 35(11):1292-1300. PubMed ID: 32584440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
    García-Alberca JM; Florido M; Cáceres M; Sánchez-Toro A; Lara JP; García-Casares N
    Psychogeriatrics; 2019 Jan; 19(1):46-54. PubMed ID: 30084177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.
    Rizvi B; Narkhede A; Last BS; Budge M; Tosto G; Manly JJ; Schupf N; Mayeux R; Brickman AM
    Neurobiol Aging; 2018 Apr; 64():25-32. PubMed ID: 29328963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC; Tsao HH; Chu YC; Wang JJ; Lee JD; Chang PY; Hsu WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):130-138. PubMed ID: 29061091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.
    Oosterman JM; Oosterveld S; Rikkert MG; Claassen JA; Kessels RP
    Int Psychogeriatr; 2012 Sep; 24(9):1474-82. PubMed ID: 22717328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
    Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
    Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.
    Akinyemi RO; Firbank M; Ogbole GI; Allan LM; Owolabi MO; Akinyemi JO; Yusuf BP; Ogunseyinde O; Ogunniyi A; Kalaria RN
    BMC Res Notes; 2015 Oct; 8():625. PubMed ID: 26519155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.